| Douglas L Greves, MD | |
|
1001 7th Street Ne, Devils Lake, ND 58301-1100 | |
| (701) 662-2157 | |
| (701) 662-4116 |
| Full Name | Douglas L Greves |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1001 7th Street Ne, Devils Lake, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265431076 | NPI | - | NPPES |
| 12620 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 3899 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Douglas L Greves, MD Po Box 1100, Devils Lake, ND 58301-1100 Ph: (701) 662-2157 | Douglas L Greves, MD 1001 7th Street Ne, Devils Lake, ND 58301-1100 Ph: (701) 662-2157 |
News Archive
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
A new study published on November 26, 2019, in the journal Cell Reports, details a new discovery that may help avert HIV infection right at the start. The virus is known to take a long time to infect a person, and the scientists say they have found a period during which it can be weakened or killed, in the very first hours after it has entered a host. They call this the window of vulnerability.
The latest approach to islet transplantation, in which clusters of insulin-producing cells known as islets are transplanted from a donor pancreas into another person's liver, has produced substantially improved results for patients with type 1 diabetes, and may offer a more durable alternative to a whole pancreas transplant.
A new study finds a wide state-by-state variation in rates of melanoma caused by ultraviolet (UV) exposure with highest rates in several states on the East and West Coast including Hawaii, but also a few landlocked states, including Utah, Vermont, and Minnesota.
Ignyta, Inc., an oncology precision medicine biotechnology company, announced today that Justin Gainor, M.D., of the Massachusetts General Hospital Cancer Center, presented preliminary results from the ongoing Phase 1 dose escalation portion of a Phase 1/2 clinical trial of RXDX-101, Ignyta's proprietary oral tyrosine kinase inhibitor targeting solid tumor indications, at the International Association for the Study of Lung Cancer 14th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
› Verified 8 days ago
Rita Nalubega, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 503 3rd St Ne, Devils Lake, ND 58301 Phone: 701-662-4300 Fax: 701-662-4322 | |
Nicole Samson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 7th Street Ne - Altru Clinic/devils Lake, Devils Lake, ND 58301 Phone: 701-662-2157 Fax: 701-780-4391 | |
Dr. Elson Tan Lim, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1031 5th Street, Devils Lake, ND 58208 Phone: 701-662-9670 | |
Stephanie Ann Foughty, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 7th St Ne Altru Clinic/devlis Lake, Devils Lake, ND 58301 Phone: 701-662-2157 | |
Heidi M Bittner, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1001 7th St Ne, Devils Lake, ND 58301 Phone: 701-662-2157 Fax: 701-662-4116 | |
Paul J Fetterly, MD, FACOG Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1001 7th St Ne, Devils Lake, ND 58301 Phone: 701-662-2157 Fax: 701-662-4116 |